Clinical Trials Directory

Trials / Sponsors / Tobira Therapeutics, Inc.

Tobira Therapeutics, Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
TerminatedAURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adult
Nonalcoholic Steatohepatitis
Phase 32017-04-05
TerminatedRollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohep
Nonalcoholic Steatohepatitis, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease
Phase 22017-02-14
CompletedPERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholang
Primary Sclerosing Cholangitis
Phase 22016-03-14
CompletedPharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
Healthy
Phase 12016-01-31
CompletedPharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination
Healthy
Phase 12016-01-31
CompletedORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus
Prediabetic State, Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus
Phase 22015-07-17
CompletedPharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination
Healthy
Phase 12014-12-01
CompletedEfficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Pa
Nonalcoholic Steatohepatitis
Phase 22014-09-18
CompletedPhase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Imp
Liver Insufficiency
Phase 12014-03-01
CompletedStudy of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
HIV-infection/AIDS
Phase 12013-03-01
CompletedEfficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada i
HIV-1 Infection
Phase 22011-06-01
CompletedA Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagoni
HIV-1 Infection
Phase 1 / Phase 22009-02-01